The pioneering new drug was found to increase average overall survival by almost five months compared to other standard ...

Researchers find that SARS-CoV-2 spike protein persists in the skull-meninges-brain axis, driving neuroinflammation, ...

A randomized controlled trial found that carrageenan, a common food additive, may cause subclinical inflammation and insulin ...

Debilitating chronic fatigue syndrome creates conditions where a kind of immune cell that identifies and kills pathogens, ...

While early and from a small trial, the findings suggest Janux’s method of “masking” T cell engagers could lead to ...

Debilitating chronic fatigue syndrome creates conditions where a kind of immune cell that identifies and kills pathogens, known as a T cell, becomes ...

Janux Therapeutics' TRACTr platform shows promise with encouraging early data. Check out what leads me to maintain a “Strong ...

REHOVOT, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- (“Purple Biotech” or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage ...

Jean C. Pfau, Ph.D. and Kinta Serve provide their perspective on asbestos, the pleural cavity, and autoimmune disease ...

Recent research has unveiled that DNA secreted by tumor cells through extracellular vesicles (EVs) can stimulate an immune response that helps inhibit the spread of tumors to the liver. This ...

Tebentafusp is the first treatment of its kind for uveal melanoma, which develops from cells in the middle layer of the eye, ...

Tebentafusp - sold under the brand name Kimmtrak - is the first treatment of its kind for uveal melanoma, which develops from ...